Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/41/e8/da/41e8dab8-61b6-1561-5a34-1b9ed15bef71/mza_16466033595733315880.jpg/600x600bb.jpg
The Psychedelic Report
Dr. Dave Rabin
51 episodes
3 months ago
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
Show more...
Medicine
Health & Fitness,
Alternative Health,
Mental Health
RSS
All content for The Psychedelic Report is the property of Dr. Dave Rabin and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.
Show more...
Medicine
Health & Fitness,
Alternative Health,
Mental Health
https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/ded6fa0a327ca62d1d49d8e51c103fc6.jpg
MDMA Therapy vs. PTSD: Which is Safer? Featuring Dr. John Miller MD
The Psychedelic Report
34 minutes
1 year ago
MDMA Therapy vs. PTSD: Which is Safer? Featuring Dr. John Miller MD
In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.

John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school  and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.

Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.

Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.

Brain Health in Exeter, New Hampshire (http://www.brain-health.co)
Psychiatric Times (http://www.psychiatrictimes.com)
https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor


https://www.linkedin.com/in/jjmillermd/


https://www.linkedin.com/company/psychiatric-times/

www.apolloneuro.com

FDA petition for MDMA-assisted therapy
https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/
The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr. Dave brings you the latest news and answers your questions to share perspectives from the front lines of this exciting movement.